<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>24(1)</volume><submitter>Raifman S</submitter><funding>Society of Family Planning</funding><pubmed_abstract>&lt;h4>Background&lt;/h4>This qualitative study aims to assess perspectives of clinicians and clinic staff on mail-order pharmacy dispensing for medication abortion.&lt;h4>Methods&lt;/h4>Participants included clinicians and staff involved in implementing a mail-order dispensing model for medication abortion at eleven clinics in seven states as part of a prospective cohort study, which began in January 2020 (before the FDA removed the in-person dispensing requirement for mifepristone). From June 2021 to July 2022, we invited participants at the participating clinics, including six primary care and five abortion clinics, to complete a semi-structured video interview about their experiences. We then conducted qualitative thematic analysis of interview data, summarizing themes related to perceived benefit</pubmed_abstract><journal>BMC women's health</journal><pagination>382</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11221167</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Primary care and abortion provider perspectives on mail-order medication abortion: a qualitative study.</pubmed_title><pmcid>PMC11221167</pmcid><pubmed_authors>Beaman J</pubmed_authors><pubmed_authors>Raifman S</pubmed_authors><pubmed_authors>Biggs MA</pubmed_authors><pubmed_authors>Gurazada T</pubmed_authors><pubmed_authors>Schwarz EB</pubmed_authors><pubmed_authors>Gold M</pubmed_authors><pubmed_authors>Grossman D</pubmed_authors></additional><is_claimable>false</is_claimable><name>Primary care and abortion provider perspectives on mail-order medication abortion: a qualitative study.</name><description>&lt;h4>Background&lt;/h4>This qualitative study aims to assess perspectives of clinicians and clinic staff on mail-order pharmacy dispensing for medication abortion.&lt;h4>Methods&lt;/h4>Participants included clinicians and staff involved in implementing a mail-order dispensing model for medication abortion at eleven clinics in seven states as part of a prospective cohort study, which began in January 2020 (before the FDA removed the in-person dispensing requirement for mifepristone). From June 2021 to July 2022, we invited participants at the participating clinics, including six primary care and five abortion clinics, to complete a semi-structured video interview about their experiences. We then conducted qualitative thematic analysis of interview data, summarizing themes related to perceived benefit</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Jul</publication><modification>2026-06-01T21:27:14.561Z</modification><creation>2025-04-04T12:22:07.37Z</creation></dates><accession>S-EPMC11221167</accession><cross_references><pubmed>38956609</pubmed><doi>10.1186/s12905-024-03202-z</doi></cross_references></HashMap>